Allison and Honjo, winners of the Nobel Prize in physiology and medicine in 2018, showed that cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed cell death protein 1 (PD-1) act as negative immune regulatory factors and inhibit anti-tumor immune response. This evidence concerns the gene CTLA4 and neoplasm.